Cargando…
Outcome after BCG treatment for urinary bladder cancer may be influenced by polymorphisms in the NOS2 and NOS3 genes()
PURPOSE: Bacillus Calmette-Guérin (BCG)-treatment is an established treatment for bladder cancer, but its mechanisms of action are not fully understood. High-risk non-muscle invasive bladder-cancer (NMIBC)-patients failing to respond to BCG-treatment have worse prognosis than those undergoing immedi...
Autores principales: | Ryk, Charlotta, Koskela, Lotta Renström, Thiel, Tomas, Wiklund, N. Peter, Steineck, Gunnar, Schumacher, Martin C., de Verdier, Petra J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556773/ https://www.ncbi.nlm.nih.gov/pubmed/26298202 http://dx.doi.org/10.1016/j.redox.2015.08.008 |
Ejemplares similares
-
Intravesical BCG treatment causes a long-lasting reduction of recurrence and progression in patients with high-risk non-muscle-invasive bladder cancer
por: Thiel, Tomas, et al.
Publicado: (2018) -
Evaluation of the Potential Association between NOS Gene Polymorphisms (iNOS G-954C and eNOS G894T) and Psoriasis
por: Duan, Xi, et al.
Publicado: (2016) -
Hélas nos chéris sont nos ennemis /
por: Plume, Amélie
Publicado: (1995) -
Association of genetic polymorphisms of eNOS with glaucoma
por: Liao, Qiong, et al.
Publicado: (2011) -
NOS3 Polymorphisms and Chronic Kidney Disease
por: Medina, Alejandro Marín, et al.
Publicado: (2018)